Sheila Rose Eshraghi, MD | |
1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131-8713 | |
(505) 272-3401 | |
Not Available |
Full Name | Sheila Rose Eshraghi |
---|---|
Gender | Female |
Speciality | Neurological Surgery |
Location | 1 University Of New Mexico, Msc10 5615, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205254299 | NPI | - | NPPES |
Entity Name | Unm Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
Air quality has been associated with numerous adverse health outcomes from asthma to pre-term birth. Researchers at University of Utah Health found women living along the Wasatch Front - the most populous region in the state of Utah - had a higher risk (16 percent) of miscarriage following short-term exposure to elevated air pollution. The results are available online on December 5 in the journal Fertility and Sterility.
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues.
Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis' PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Sheila Rose Eshraghi, MD 1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131-0001 Ph: (505) 272-3401 | Sheila Rose Eshraghi, MD 1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131-8713 Ph: (505) 272-3401 |
News Archive
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
Air quality has been associated with numerous adverse health outcomes from asthma to pre-term birth. Researchers at University of Utah Health found women living along the Wasatch Front - the most populous region in the state of Utah - had a higher risk (16 percent) of miscarriage following short-term exposure to elevated air pollution. The results are available online on December 5 in the journal Fertility and Sterility.
In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues.
Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis' PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.
› Verified 3 days ago
Dr. Gerald Nathan Gold, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1509 Harvard Ct Ne, Albuquerque, NM 87106 Phone: 505-255-0555 | |
Mehrnoush Gorjian, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: Department Of Neurosurgery 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4280 | |
Daniel Shibuya, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne, Ste 401, Albuquerque, NM 87102 Phone: 505-727-5910 Fax: 505-727-5939 | |
Dr. James Andrew Botros, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-3401 | |
Paul Turner, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5-north University Hospital, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-3160 | |
Dr. Chad Douglas Cole, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-0621 |